Seeking Alpha
 

Actavis plc. (ACT)

- NYSE
  • joelkatz | Send Message 2 Mar

    $ACT will be ranked as the second-largest corporate bond ever ($20 B) and further propel bond sales this year into record territory.
    Reply
      • joelkatz | Send Message 2 Mar

        And the good news for $ACT keeps flowing The European Commission approves Actavis subsidiary Durata Therapeutics International's Xydalba
        Reply (1)
        • joelkatz | Send Message 2 Mar
          : for the treatment of adult patients acute bacterial skin and skin structure infections (ABSSSI), the first 1-weekly IV antibiotic approved.
          • joelkatz | Send Message 2 Mar

            $ACT Actavis price target raised to USD 350 from USD 315 at Bernstein. In other news $ACT to issue bonds in ammount of $20B. Bullish!
            Reply
              • joelkatz | Send Message 20 Feb

                $ACT making new highs!!!
                Reply
                  • joelkatz | Send Message 18 Feb

                    My latest purchase was $ACT at $286.90 yesterday at the close
                    Reply
                      • joelkatz | Send Message 17 Feb

                        $ACT eyeing to get in
                        Reply
                          • Jehan Ghandhy | Send Message 17 Feb

                            Pharmaceuticals - Is Organic Growth No Longer Enough? $AGN, $ACT http://seekingalpha.com/a/1qmpw
                            Reply
                              • SA Editor Mike Taylor | Send Message 13 Feb
                                Reply
                                  • SA Editor Mike Taylor | Send Message 13 Feb

                                    Next week in biotech/healthcare: Expected earnings from $ACT $AGIO $ARIA $ETRM $INSV $MNTA $VNDA XNPT -- any others/thoughts?
                                    Reply
                                      • Michael Bryant | Send Message 5 Feb

                                        "Allergan reported adj. quarterly profit of $2.17 per share, 34 cents above estimates." Buy Actavis ($ACT). http://yhoo.it/1LPZTyX
                                        Reply
                                          Visit Seeking Alpha's
                                          ACT vs. ETF Alternatives
                                          Company Description
                                          Actavis PLC specialty pharmaceutical company engaged in developing, manufacturing and distributing generic, brand and biosimilar products.
                                          Sector: Healthcare
                                          Industry: Drugs - Generic
                                          Country: United States